介入栓塞材料在肝癌治疗中的研究进展  

Research progress of interventional embolization materials in the treatment of liver cancer

作　　者：曾嘉 何东风[1] Jia Zeng;Dongfeng He(Department of Interventional Radiology,Cancer Hospital Affiliated to Harbin Medical University,Heilongjiang Harbin 150000,China)

机构地区：[1]哈尔滨医科大学附属肿瘤医院介入科,黑龙江哈尔滨150000

出　　处：《中华介入放射学电子杂志》2023年第1期62-67,共6页Chinese Journal of Interventional Radiology：electronic edition

摘　　要：在全世界范围内,肝癌是恶性肿瘤相关死亡的第四大常见原因,其中最主要的是肝细胞癌(hepatocellular carcinoma,HCC)。经导管动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)介入治疗是中晚期HCC的首选治疗方式,近年来国内外关于介入栓塞材料也展开了诸多研究,文章拟对介入栓塞材料在肝癌治疗中的研究进展作相关综述,以期给临床栓塞材料的选择提供参考。Liver cancer is the fourth leading cause of malignant tumor-related death worldwide,the most prominent type of which is hepatocellular carcinoma(HCC).Transcatheter arterial chemoembolization(TACE)is the preferred treatment option for advanced HCC.In recent years,many researches on interventional embolization materials have been carried out at home and abroad.This article intends to review the research progress of interventional embolization materials in the treatment of liver cancer,with a view to provide reference for clinical embolization material selection.

关 键 词：动脉化疗栓塞 栓塞材料 肝癌介入治疗 载药微球 可降解淀粉微球 

分 类 号：R735.7[医药卫生—肿瘤]